1. Contractors
  2. Immuno Mycologies Inc

Immuno Mycologies Inc

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Immuno Mycologies has 6 federal contracts of $100,000 or more active since October 2023, with $2.23M obligated, from 2 agencies. 1 is still running, 1 ending within 18 months.

Contracts
6 since FY2024$2,234,411 obligated, contracts of $100,000 or more
Running now
1 contract1 ended in the last 12 months
Biggest customer
National Institutes of Health$1.71M on 2 contracts
UEI
CN4DMLCJGCK9Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$210,000
FY2022$1,499,709
FY2024$146,563
FY2025$259,293
FY2026$118,846

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Fungal Complement Fixation and Immunodiffusion TestingDepartment of Veterans Affairs · 36C24926N0334$118,846Jan 18, 2027in 2 monthsOK

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
National Institutes of Health2 contracts$1,709,709
Department of Veterans Affairs4 contracts$524,702

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts$1,709,709
In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 4 contracts$524,702

Where the work is

Place of workAmount
Oklahoma6 contracts$2,234,411

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.

Get new notices like Immuno Mycologies's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy